A randomized unblinded trial to compare effects of intensive versus conventional lipid-lowering therapy in patients undergoing renal artery stenting.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of cardiology"
DOI: 10.1016/j.jjcc.2019.04.010
Abstract: BACKGROUND Although current guidelines recommend the use of statins for severe atherosclerotic renal artery stenosis (ARAS), the renal protection of intensive lipid-lowering therapy in patients with ARAS who underwent stent placement remains uncertain. The aim… read more here.
Keywords: iqr; renal artery; lowering therapy; conventional lipid ... See more keywords
Impact of conventional lipid-lowering therapy on circulating levels of PCSK9: protocol for a systematic review and meta-analysis of randomised controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-061884
Abstract: Introduction Conventional lipid-lowering agents, including statins, ezetimibe, fibrates, bile acid sequestrants, nicotinic acid, bempedoic acid and Omega-3, are essential to the management of dyslipidaemia. However, these agents have been shown to increase the level of… read more here.
Keywords: conventional lipid; review; controlled trials; acid ... See more keywords